StockOtters
StockOttersSupply Chain Map
AptaBio Therapeutics Inc. logo

AptaBio Therapeutics Inc.

293780.KQ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
3
Cost of Revenue
2
Gross Profit
0
Gross Margin
8.5%
Operating Income
-14
Operating Margin
-561.0%
Net Income
-22
Net Margin
-874.1%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-18
EBITDA Margin
-710.2%

2023

12/31/2023

Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
18.9%
Operating Income
-12
Operating Margin
-5055.6%
Net Income
-9
Net Margin
-3724.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-10
EBITDA Margin
-4015.4%

2022

12/31/2022

Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
76.9%
Operating Income
-7
Operating Margin
-19610.9%
Net Income
-8
Net Margin
-21849.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-8
EBITDA Margin
-20887.6%

2021

12/31/2021

Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
98.1%
Operating Income
-9
Operating Margin
-5071.0%
Net Income
-8
Net Margin
-4778.8%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-8
EBITDA Margin
-4634.9%

2020

12/31/2020

Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
98.8%
Operating Income
-5
Operating Margin
-1772.9%
Net Income
-3
Net Margin
-1149.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-1075.1%